rs876657691
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000503.6(EYA1):c.896C>A(p.Ser299*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000503.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EYA1 | NM_000503.6 | c.896C>A | p.Ser299* | stop_gained | Exon 10 of 18 | ENST00000340726.8 | NP_000494.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Rare genetic deafness Pathogenic:1
The p.Ser299X variant in EYA1 has not been previously reported in individuals wi th Branchio-oto-renal syndrome or in large population studies. This nonsense var iant leads to a premature termination codon at position 299, which is predicted to lead to a truncated or absent protein. Heterozygous loss of function of the E YA1 gene is an established disease mechanism in Branchio-oto-renal syndrome. In summary, this variant meets our criteria to be classified as pathogenic for Bran chio-oto-renal syndrome in an autosomal dominant manner based on the predicted i mpact to the protein. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at